Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
198.80    -3.80 (-1.88%)
Bid:
198.70
Ask:
199.20
Spread: 0.50 (0.252%)
Market Cap: £1.29b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

14 Oct 2022 07:00

RNS Number : 8631C
Ashmore Group PLC
14 October 2022
 

 

Ashmore Group plc14 October 2022

FIRST QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 30 September 2022.

Assets under management

Theme

Actual30 June 2022

(US$ billion)

Estimated30 September 2022

(US$ billion)

Movement

 (%)

- External debt

14.4

11.9

-17.4%

- Local currency

20.6

18.3

-11.2%

- Corporate debt

6.8

6.1

-10.3%

- Blended debt

14.4

12.3

-14.6%

Fixed income

56.2

48.6

-13.5%

Equities

6.3

5.9

-6.3%

Alternatives

1.5

1.5

-

Total

64.0

56.0

-12.5%

 

Assets under management declined by US$8.0 billion over the period, comprising net outflows of US$5.0 billion and negative investment performance of US$3.0 billion.

The net outflows were predominantly a result of institutional investors reducing exposure in the external debt, local currency and blended debt themes, and local currency flows also include net redemptions of US$0.8 billion from overlay funds. The corporate debt and equity themes experienced small net outflows.

Continued high levels of inflation and consequently more hawkish central banks around the world meant that the main Emerging Markets fixed income indices declined by between 3% and 6% over the quarter, while equity indices fell by between 2% and 12%. Relative performance over the period, and the longer term, is consistent with the recent pattern of outperformance in local currency, equities and investment grade products, and some underperformance in fixed income strategies with a high yield bias.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

 "Global fixed income and equity markets fell over the quarter reflecting continued uncertainty around geopolitical risks, higher inflation and increasingly hawkish central banks. This has increased the risk of recession in many countries and pushed bond yields higher and equity valuations lower in both Developed and Emerging Markets. Investor risk appetite therefore remains limited in the near term and Ashmore's AuM movement this quarter reflects the impact of lower market levels and investors continuing to reduce risk.

"Valuations across equity and fixed income Emerging Markets are exceptionally attractive and yet investors have lighter positions following a period of lower risk appetite. This provides a firm foundation for performance and higher allocations to capture the longer term growth and investment opportunities available in Emerging Markets as macro economic conditions begin to improve. Ashmore's active management means it can take advantage of attractive market levels to embed value in portfolios and consequently it is well positioned to deliver outperformance in the years ahead across its range of equity and fixed income strategies."

 

Notes

Local currency AuM includes US$6.3 billion of AuM managed in overlay/liquidity strategies (30 June 2022: US$7.2 billion).

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingNeil Doyle +44 (0)7771 978 220Kit Dunford +44 (0)7717 417 038

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFERIELVLIF
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.